A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models
暂无分享,去创建一个
S. Ramaswamy | Gillian Smith | Zebin Wang | K. Sun | Zhi-yi Zhang | K. Mikule | J. Hanke | G. Poon | Aparajitha Vaidyanathan | J. Wang | Sridhar Ramaswamy